BLFG
VRTX icon

Brian Low Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Brian Low Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Buy
542
+6
+1% +$2.66K 0.16% 96
2026
Q1 		$239K Buy
536
+13
+2% +$6.06K 0.16% 103
2025
Q4 		$237K Buy
+523
New +$225K 0.17% 104

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Brian Low Financial Group's VRTX Position: Q2 2026 in Review

Brian Low Financial Group increased its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q2 2026, buying an estimated $2.66K and bringing the position to 542 shares worth $269K. The position accounts for 0.16% of the portfolio, ranked #96.

Brian Low Financial Group first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Brian Low Financial Group held 542 shares of Vertex Pharmaceuticals worth $269K as of Q2 2026.
  • Brian Low Financial Group bought 6 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.66K.
  • Vertex Pharmaceuticals made up 0.16% of Brian Low Financial Group's portfolio in Q2 2026, its #96 holding.
  • Brian Low Financial Group first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Brian Low Financial Group's 13F filing for Q2 2026, filed 28 Jul 2026.